Medical News

RSS

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues

NexBio, Inc. announced today the publication "DAS181 Inhibits H5N1 Influenza Lung Virus Infection of Human Lung Tissues" in the September, 2009 issue of the journal Antimicrobial Agents and Chemotherapy (AAC).

26 Aug 2009

Veteran’s Administration Medical Center awards contract to Pioneer Behavioral Health for providing behavioral health services

PHC, Inc., d.b.a. Pioneer Behavioral Health (NYSE AMEX: PHC), a leading provider of inpatient and outpatient behavioral health services, announced today that it has been awarded a contract by the Salt Lake City Veteran’s Administration Medical Center (VA) to provide behavioral health services at the Company’s Highland Ridge Hospital in Salt Lake City, Utah. The initial term of the contract is nine months, with six-month renewal periods.

26 Aug 2009

HealthCore study reports that oral controllers provide better clinical outcomes for asthma patients

Mayo Clinic Proceedings published a peer-reviewed comparative effectiveness study performed by HealthCore, Inc. in its August edition. The study demonstrated that in general had better clinical outcomes with oral controllers than inhaled corticosteroids.

26 Aug 2009

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

26 Aug 2009

Modest decline for hypertension drug industry over the next decade

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents -- most notably Novartis's Diovan -- the hypertension drug market will experience only modest decline over the next decade.

26 Aug 2009

AOFAS announces results of clinical trials with the STAR ankle replacement device

Charles L. Saltzman, MD, newly-elected president of the American Orthopaedic Foot & Ankle Society (AOFAS), presented the results of a groundbreaking study at the recent AOFAS 2009 Annual Summer Meeting in Vancouver, British Columbia, Canada.

26 Aug 2009

Blue Cross and Blue Shield of Kansas City selects UMB Healthcare Services to provide Health Savings Accounts to its customers

UMB Healthcare Services, a division of UMB Financial Corporation (NASDAQ: UMBF), announced today that they were selected by Blue Cross and Blue Shield of Kansas City to provide Health Savings Accounts (HSA) to its customers.

26 Aug 2009

Safeguard Scientifics' annual shareholder meeting at Pennsylvania, USA will have live webcast

Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.

26 Aug 2009

Sebelius names Chair of Presidential Advisory Council on HIV/AIDS

HHS Secretary Kathleen Sebelius on Monday named Helene Gayle, president and chief executive of the charity CARE USA, as the chair the Presidential Advisory Council on HIV/AIDS, Reuters reports.

26 Aug 2009

TBI and NWTS to serve surgeons and hospitals by supplying transplantable tissues

TBI/Tissue Banks International, one of the nation's largest eye and tissue banking networks, and Northwest Tissue Services (NWTS), a Puget Sound Blood Center program, have entered into a partnership that will allow both organizations to more efficiently serve surgeons and hospitals that rely on them for transplantable tissue.

26 Aug 2009

Urologix announces fiscal 2009 fourth-quarter and full-year financial results

Urologix®, Inc. (NASDAQ:ULGX), a medical device company focused on developing, manufacturing and marketing Cooled ThermoTherapy™ systems, a durable and effective catheter based in-office alternative to drugs or surgery for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for the fourth quarter ended June 30, 2009 and for fiscal year 2009.

26 Aug 2009

Hearatlast to reduce operating costs significantly through restructuring

HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today that through the addition of Louis Isabella; CFO; and the Evans Martin group, the Company has identified several significant cost cutting measures.

26 Aug 2009

Recent study shows that eDetailing is a viable means for reaching prescribers

For pharmaceutical sales forces, eDetailing has reemerged as a viable means for reaching prescribers. A recent study by Cutting Edge Information shows that drug companies are implementing eDetailing tools -- and are investing more money than ever in this sales channel.

26 Aug 2009

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

USANA Health Sciences, Inc. announced today that results of a large, third-party clinical study involving USANA products, conducted at the University of Colorado Denver (UCD), have been published in the August 2009 edition of the journal Obesity and Weight Management.

26 Aug 2009

Pegasystems' business process management solution certified for full integration with Milliman Care Guidelines' CareWebQI

The Pegasystems Care Management Framework (CMF) is the first application certified as fully integrated with Milliman Care Guidelines's interactive CareWebQI((R)) clinical guideline software under a new Integration Certification program. CMF, a patient-centric business process management solution designed to improve the entire care management continuum, proved its optimum clinical workflow and usability with CareWebQI through a rigorous validation process.

26 Aug 2009

Peptimmune's Phase Ib clinical trial of PI-2301 in multiple sclerosis patients complete

Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.

26 Aug 2009

Cardium announced that patients enrolled for MATRIX clinical trail have completed their evaluation period

Cardium Therapeutics (NYSE Amex: CXM) today announced that all patients enrolled in the Company's MATRIX clinical study have now completed their initial 12-week evaluation period and that it plans to provide detailed safety and efficacy data in late September 2009.

26 Aug 2009

Verisk Health signs six new contracts for use of its healthcare data analytic software

Verisk Health, Inc., a global leader in healthcare data analytics, announced today signings in June and July of six new contracts for use of the Company’s healthcare analytics, clinical resource management, risk assessment, and predictive modeling software.

26 Aug 2009

Healthy San Francisco enrollees express high levels of satisfaction with city's health access program and survey shows signs of improved access to care

As states and cities struggle with the economic recession and possible fiscal pressure on public health care programs, a new Kaiser Family Foundation survey of enrollees in Healthy San Francisco (HSF), the city's health care access program for the uninsured, reports high rates of satisfaction and signs that the program has improved access to care for those uninsured residents who have enrolled.

26 Aug 2009

PD2i algorithm published in Therapeutics and Clinical Risk Management can predict risk of sudden cardiac death

David H. Fater, CEO of Vicor Technologies, Inc., today announced that original research conducted using its PD2i algorithm to prospectively predict risk of sudden cardiac death was published in Therapeutics and Clinical Risk Management.

26 Aug 2009

Medical News

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues

Veteran’s Administration Medical Center awards contract to Pioneer Behavioral Health for providing behavioral health services

HealthCore study reports that oral controllers provide better clinical outcomes for asthma patients

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Modest decline for hypertension drug industry over the next decade

AOFAS announces results of clinical trials with the STAR ankle replacement device

Blue Cross and Blue Shield of Kansas City selects UMB Healthcare Services to provide Health Savings Accounts to its customers

Safeguard Scientifics' annual shareholder meeting at Pennsylvania, USA will have live webcast

Sebelius names Chair of Presidential Advisory Council on HIV/AIDS

TBI and NWTS to serve surgeons and hospitals by supplying transplantable tissues

Urologix announces fiscal 2009 fourth-quarter and full-year financial results

Hearatlast to reduce operating costs significantly through restructuring

Recent study shows that eDetailing is a viable means for reaching prescribers

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

Pegasystems' business process management solution certified for full integration with Milliman Care Guidelines' CareWebQI

Peptimmune's Phase Ib clinical trial of PI-2301 in multiple sclerosis patients complete

Cardium announced that patients enrolled for MATRIX clinical trail have completed their evaluation period

Verisk Health signs six new contracts for use of its healthcare data analytic software

Healthy San Francisco enrollees express high levels of satisfaction with city's health access program and survey shows signs of improved access to care

PD2i algorithm published in Therapeutics and Clinical Risk Management can predict risk of sudden cardiac death

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News